A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The authors performed a case-cohort study nested within the Atherosclerosis Risk in Communities (ARIC) Study to determine the association between plasma ferritin level and risk of type 2 diabetes mellitus. Persons with incident cases of type 2 diabetes diagnosed over an average follow-up period of 7.9 years (n = 599) were compared with a random sample of the cohort (n = 690). After adjustment for age, gender, menopausal status, ethnicity, center, smoking, and alcohol intake, the hazard ratio for diabetes, comparing the fifth quintile of ferritin with the first quintile, was 1.74 (95% confidence interval: 1.14, 2.65; p-trend < 0.001). After further adjustment for body mass index and components of the metabolic syndrome, the hazard ratio was 0.81 (95% confidence interval: 0.49, 1.34; p-trend = 0.87). From a causal perspective, there are two alternative interpretations of these findings. Elevated iron stores, reflected in elevated plasma ferritin levels, may induce baseline metabolic abnormalities that ultimately result in diabetes. Alternatively, elevated ferritin may be just one of several metabolic abnormalities related to the underlying process that ultimately results in diabetes, rather than a causal factor for diabetes. Longitudinal studies with repeated measurements of glucose and iron metabolism parameters are needed to establish the role of iron stores and plasma ferritin in diabetes development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum ferritin and body iron stores are strongly associated with diabetes [603,605-609], including prospectively [610]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1989) · PubMed · Cited by 3,139
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 1×
“In addition, ferritin levels may be increased in response to oxidative stress (31–34), to nitric oxide signaling (34–36), and to several inflammatory cytokines (34, 37, 38)—three mechanisms that are involved in the pathogenesis of the metabolic syndrome (39–41).”
BackgroundFerritin: a cytoprotective antioxidant strategem of endothelium.
Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., & Vercellotti, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37165-0 · Cited by 1,097
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Self-citationCross-Talk Between Iron Metabolism and Diabetes
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2348 · Cited by 704
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 659
I RON R EGULATORY P ROTEINS AND THE M OLECULAR C ONTROL OF M AMMALIAN I RON M ETABOLISM
Eisenstein, R. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.627 · Cited by 653
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
Jiang, R. (2004) · JAMA · doi:10.1001/jama.291.6.711 · Cited by 598
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Ferritin and the response to oxidative stress
ORINO, K., LEHMAN, L., TSUJI, Y., AYAKI, H., TORTI, S. V., & TORTI, F. M. (2001) · Biochemical Journal · doi:10.1042/bj3570241 · Cited by 535
Insulin resistance–associated hepatic iron overload
Mendler, M.-H., Turlin, B., Moirand, R., Jouanolle, A.-M., Sapey, T., Guyader, D., le Gall, J.-Y., Brissot, P., David, V., & Deugnier, Y. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70401-4 · Cited by 501
Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults
Jehn, M., Clark, J. M., & Guallar, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2422 · Cited by 443
Self-citationDiabetes and serum ferritin concentration among U.S. adults.
Ford, E. S., & Cogswell, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1978 · Cited by 419 · cited 1×
“Levels of plasma ferritin, a biomarker of iron stores, are elevated in persons with prevalent diabetes as compared with nondiabetic controls (2, 5).”
BackgroundSerum Ferritin as a Component of the Insulin Resistance Syndrome
Fernández-Real, J.-M., Ricart-Engel, W., Arroyo, E., Balançá, R., Casamitjana-Abella, R., Cabrero, D., Fernández-Castañer, M., & Soler, J. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.62 · Cited by 328 · cited 1×
“Markers of iron status are also correlated with the prevalence of the metabolic syndrome (6, 7) and with measures of insulin”
BackgroundWitte, D. L., Crosby, W. H., Edwards, C. Q., Fairbanks, V. F., & Mitros, F. A. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06212-2 · Cited by 321
Chambless, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.1.38 · Cited by 321
Tuomainen, T.-P., Nyyssönen, K., Salonen, R., Tervahauta, A., Korpela, H., Lakka, T., Kaplan, G. A., & Salonen, J. T. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.426 · Cited by 312
Coordinate Transcriptional and Translational Regulation of Ferritin in Response to Oxidative Stress
Tsuji, Y., Ayaki, H., Whitman, S. P., Morrow, C. S., Torti, S. V., & Torti, F. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5818-5827.2000 · Cited by 285
Relation between iron stores and non-insulin dependent diabetes in men: case-control study
Salonen, J. T., Tuomainen, T.-P., Nyyssönen, K., Lakka, H.-M., & Punnonen, K. (1998) · BMJ · doi:10.1136/bmj.317.7160.727 · Cited by 242
Secretion of Ferritin by Rat Hepatoma Cells and Its Regulation by Inflammatory Cytokines and Iron
Tran, T. N., Eubanks, S. K., Schaffer, K. J., Zhou, C. Y. J., & Linder, M. C. (1997) · Blood · doi:10.1182/blood.v90.12.4979 · Cited by 236
Coronary Heart Disease and Iron Status: Meta-Analyses of Prospective Studies
Danesh, J., & Appleby, P. (1999) · Circulation · doi:10.1161/01.cir.99.7.852 · Cited by 226 · cited 1×
“However, the accumulated evidence indicates that ferritin levels are not associated with increased cardiovascular disease risk in prospective studies (48, 49).”
BackgroundPantopoulos, K., & Hentze, M. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1267 · Cited by 220
Tanner, L. I., & Lienhard, G. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48032-5 · Cited by 193
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Niederau, C., Berger, M., Stremmel, W., Starke, A., Strohmeyer, G., Ebert, R., Siegel, E., & Creutzfeldt, W. (1984) · Diabetologia · doi:10.1007/bf00262217 · Cited by 178
Potential Role of Increased Iron Stores in Diabetes
Wilson, J. G., Maher, J. F., Lindquist, J. H., Grambow, S. C., & Crook, E. D. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200306000-00004 · Cited by 176 · cited 2×
“Iron overload may induce insulin resistance by reducing insulin extraction in the liver (20–23) or by reducing insulin synthesis and excretion by the pancreatic beta cells (4, 24).”
BackgroundFasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes
Pankow, J. S., Duncan, B. B., Schmidt, M. I., Ballantyne, C. M., Couper, D. J., Hoogeveen, R. C., & Golden, S. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.77 · Cited by 166
Self-citationInsulin resistance, iron, and the liver
Ferrannini, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02397-7 · Cited by 161
On fitting Cox's proportional hazards models to survey data
Lin, D. Y. (2000) · Biometrika · doi:10.1093/biomet/87.1.37 · Cited by 155
Inflammation, insulin resistance, and obesity
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0082-x · Cited by 151
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 128
Association Between Inflammation and Insulin Resistance in U.S. Nondiabetic Adults
Chen, J., Wildman, R. P., Hamm, L. L., Muntner, P., Reynolds, K., Whelton, P. K., & He, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2960 · Cited by 127
Hepatic steatosis and type 2 diabetes mellitus
Clark, J. M., & Diehl, A. M. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0085-3 · Cited by 117
Self-citationFactors determining glucose tolerance in patients with thalassemia major
Dmochowski, K. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.478 · Cited by 116
Hsiao, T.-J., Chen, J., & Wang, J.-D. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802519 · Cited by 115
Cario, H., Holl, R. W., Debatin, K., & KOHNE, E. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1121-7 · Cited by 113
The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study
Rahier, J., Loozen, S., Goebbels, R., & Abrahem, M. (1987) · Diabetologia · doi:10.1007/bf01788899 · Cited by 109
No Association between Serum Ferritin and Asymptomatic Carotid Atherosclerosis
Moore, M., Folsom, A. R., Barnes, R. W., & Eckfeldt, J. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117493 · Cited by 98
Haap, M. M., Fritsche, A., Hj, M., H�ring, H.-U., & Stümvoll, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00029 · Cited by 91
Insulin resistance and hyperinsulinemia in homozygous β-thalassemia
Cavallo‐Perin, P., Pacini, G., Cerutti, F., A., B., Condo, C., Sacchetti, L., Piga, A. G., & Pagano, G. (1995) · Metabolism · doi:10.1016/0026-0495(95)90155-8 · Cited by 80
Yokomori, N., Iwasa, Y., Aida, K., INOUE, M., Tawata, M., & Onaya, T. (1991) · Endocrinology · doi:10.1210/endo-128-3-1474 · Cited by 77
SUDAAN User's Manual, Release 9.0
Witt, M., & Barnwell, B. (2004) · Cited by 76
Mechanisms of endothelial dysfunction in the metabolic syndrome
DEEDWANIA, P. C. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0019-8 · Cited by 73
Lee, D.-H., & Jacobs, D. R. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00344-x · Cited by 54 · cited 2×
“Other biomarkers of iron, such as non-transferrin-bound iron, may be needed to evaluate the impact of iron on disease development (47).”
BackgroundHealth Implications of Iron Overload: the Role of Diet and Genotype
Heath, A. M., & Fairweather‐Tait, S. J. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.febr.45-62 · Cited by 53
PLASMA FERRITIN AND TYPE 2 DIABETES MELLITUS: A CRITICAL REVIEW
Eshed, I., Elis, A., & Lishner, M. (2001) · Endocrine Research · doi:10.1081/erc-100107172 · Cited by 45
Serum ferritin: Does it differ from tissue ferritin?
Linder, M. C., Schaffer, K. J., Hazegh-Azam, M., Zhou, C. Y. J., Tran, T. N., & Nagel, G. M. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00030.x · Cited by 44
Sempos, C. T., & Looker, A. C. (2001) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(00)00153-4 · Cited by 26
(1998) · PubMed
Cited by
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“prospectively [610], while changes in visfatin are also”
BackgroundThe Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
“(61) argue that the modest elevations in ferritin levels observed in diabetes may be a consequence or marker rather than the cause of impending insulin resistance and that elevated ferritin may not reflect elevated body iron stores or an intracellular labile iron pool that participates in oxidant injury.”
BackgroundThe role of iron in type 2 diabetes in humans
Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.005 · Cited by 363
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…et al. 2001; Fernández-Real et al. 2002; Ford and Cogswell 1999; Forouhi et al. 2007; He et al. 2007; Hubel et al. 2004; Ishizaka et al. 2005; Jehn et al. 2004, 2007; Kaur et al. 2007; Kiechl et al. 1997; Lee et al. 2006f; Lim et al. 2001; Rayman et al. 2002; Rouault 2006; Salonen et al.…”
Metadata
- Authors
- Jehn, M. L., Guallar, E., Clark, J. M., Couper, D., Duncan, B. B., Ballantyne, C. M., Hoogeveen, R. C., Harris, Z. L., & Pankow, J. S.
- Affiliations
- Johns Hopkins University (US)
- University of North Carolina at Chapel Hill (US)
- Universidade Federal do Rio Grande do Sul (BR)
- Baylor College of Medicine (US)
- University of Minnesota (US)
- ORCID
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-25
- Volume
- 165
- Issue
- 9
- Pages
- 1047-1054
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2149560259
- Cited by
- 136
- References
- 50
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 8 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 16 · 2012: 12
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC55022, N01-HC-55018, N01 HC 55020, N01 HC 55019, N01-HC55016, N01‐HC‐55015, N01-HC55021)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- plasma ferritin, type 2 diabetes, iron stores, incident diabetes risk, metabolic syndrome, body mass index, causal interpretation, iron metabolism, Atherosclerosis Risk in Communities Study
- MeSH terms
- Arteriosclerosis, Diabetes Mellitus, Type 2, Female, Ferritins, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Body Mass Index, Incidence, Proportional Hazards Models, Case-Control Studies, Risk Assessment, Iron Overload
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.